Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion

Journal of Molecular Neuroscience

Volumn 42, Issue 3, 2010, Pages 411-418

  Horvath, Gabriella ^a   Racz, Boglarka ^a   Reglodi, Dora ^a   Kovacs, Krisztina ^a   Kiss, Peter ^a   Gallyas Jr , Ferenc ^a   Bognar, Zita ^a   Szabo, Aliz ^a   Magyarlaki, Tamas ^a   Laszlo, Eszter ^a   Lubics, Andrea ^a   Tamas, Andrea ^a   Toth, Gabor ^b   Szakaly, Peter ^c  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Apoptosis; Bcl 2; Cytokine; Renal ischemia reperfusion

Indexed keywords

CHEMOKINE; CYTOKINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; IN VITRO STUDY; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; MALE; MEMBRANE PERMEABILITY; MITOCHONDRION; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CHEMOKINES; CYTOKINES; KIDNEY; MALE; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; REPERFUSION INJURY;

RATTUS;

EID: 78349313721     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9342-0     Document Type: Article

References (53)

1. C Abad RP Gomariz JA Waschek 2006 Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP Curr Top Med Chem 6 151 163 1:CAS:528:DC%2BD28XitVantrg%3D 10.2174/156802606775270288 16454764
2. A Arimura M Li V Batuman 2006 Potential protective action of pituitary adenylate cyclase activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury Blood 107 661 668 1:CAS:528: DC%2BD28Xms1ersg%3D%3D 10.1182/blood-2005-03-1186 16204306
3. A Arimura M Li V Batuman 2006 Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38 Ann N Y Acad Sci 1070 1 4 1:CAS:528:DC%2BD28XpvVehsL8%3D 10.1196/annals.1317.093 16888145
4. Atlasz T, Szabadfi K, Kiss P et al (2010) Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration. Brain Res Bull 81:497-504
5. N Aubert A Falluel-Morel D Vaudry, et al. 2006 PACAP and C2-ceramide generate AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression J Neurochem 99 1237 1250 1:CAS:528:DC%2BD28Xht1yks7jJ 10.1111/j.1471-4159.2006.04148.x 17026529
6. WA Banks D Uchida A Arimura, et al. 1996 Transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons Ann N Y Acad Sci 805 270 277 1:CAS:528:DyaK2sXhtVegsbc%3D 10.1111/j.1749-6632.1996.tb17489.x 8993409
7. DP Basile DR Martin MR Hammerman 1998 Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-beta in repair Am J Physiol 275 F894 F903 1:CAS:528:DyaK1MXht1Oqsg%3D%3D 9843906
8. Z Bognar T Kalai A Palfi, et al. 2006 A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death Free Radic Biol Med 41 835 848 1:CAS:528: DC%2BD28XotVyqtLg%3D 10.1016/j.freeradbiomed.2006.06.004 16895804
9. CC Chen ZM Liu HH Wang, et al. 2004 Effects of ulinastatin on renal ischemia-reperfusion injury in rats Acta Pharmacol Sin 25 1334 1340 1:CAS:528:DC%2BD2cXovVeqsbg%3D 15456536
10. CT Chien SK Shyue MK Lai 2007 Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy Transplantation 84 1183 1190 1:CAS:528:DC%2BD2sXht1yku77I 10.1097/01.tp. 0000287334.38933.e3 17998875
11. A Dejda V Jolivel S Bourgault, et al. 2008 Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases J Mol Neurosci 36 26 37 1:CAS:528:DC%2BD1cXhsVagtLjM 10.1007/s12031-008-9087-1 18506634
12. M Delgado D Ganea 2000 VIP and PACAP inhibit activation induced apoptosis in T lymphocytes Ann N Y Acad Sci 921 55 67 1:CAS:528:DC%2BD3MXntVahsA%3D%3D 10.1111/j.1749-6632.2000.tb06951.x 11193880
13. M Delgado D Ganea 2001 Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide in vitro and in vivo J Immunol 167 966 975 1:CAS:528:DC%2BD3MXotFWktL0%3D 11441105
14. A Falluel-Morel N Aubert D Vaudry, et al. 2004 Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells J Neurochem 91 1231 2143 1:CAS:528:DC%2BD2cXhtFSitr%2FN 10.1111/j.1471-4159.2004.02810.x 15569266
15. A Ferencz B Racz A Tamas, et al. 2009 Influence of PACAP on oxidative stress and tissue injury following small bowel autotransplantation J Mol Neurosci 37 168 176 1:CAS:528:DC%2BD1cXhsFarsbvJ 10.1007/s12031-008-9132-0 18651248
16. M Fischereder 2007 Chemokines and chemokine receptors in renal transplantation-from bench to bedside Acta Physiol Hung 94 67 81 1:CAS:528:DC%2BD2sXkslSmt7k%3D 10.1556/APhysiol.94.2007.1-2.7 17444276
17. D Ganea M Delgado 2002 Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) as modulators of both innate and adaptive immunity Crit Rev Oral Biol Med 13 229 237 10.1177/ 154411130201300303 12090463
18. SM Gardiner T Rakhit PA Kemp JE March T Bennett 1994 Regional haemodynamic responses to pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in conscious rats Br J Pharmacol 111 589 597 1:CAS:528:DyaK2cXhvVensrc%3D 7911721
19. B Gasz B Racz E Roth, et al. 2006 Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis Peptides 27 87 94 1:CAS:528:DC%2BD28Xktl2nug%3D%3D 10.1016/j.peptides.2005.06. 022 16095757
20. BM Girard A Wolf-Johnston KM Brras LA Birder V May MA Vizzard 2008 PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis J Mol Neurosci 36 310 320 1:CAS:528:DC%2BD1cXhsVagtLjL 10.1007/s12031-008-9104-4 18563302
21. RP Gomariz Y Juarranz C Abad A Arranz J Leceta C Martinez 2006 VIP-PACAP system in immunity. New insights for multitarget therapy Ann N Y Acad Sci 1070 51 74 1:CAS:528:DC%2BD28XpvVehsLg%3D 10.1196/annals.1317.031 16888149
22. H Hasegawa M Kohno M Sasaki, et al. 2003 Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice Arthritis Rheum 48 2555 2566 1:CAS:528:DC%2BD3sXot1WjtrY%3D 10.1002/art.11231 13130475
23. M Hautmann UG Friis M Desch, et al. 2007 Pituitary adenylate cyclase activating polypeptide stimulates renin secretion via activation of PAC1 receptors J Am Soc Nephrol 18 1150 1156 1:CAS:528:DC%2BD2sXkslSrsL0%3D 10.1681/ASN.2006060633 17360952
24. G Horvath L Mark R Brubel, et al. 2010 Mice deficient in pitutiary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro Neurosci Lett 469 70 74 1:CAS:528:DC%2BC3cXotFCq 10.1016/j.neulet.2009.11.046 19932736
25. S Jain GR Bicknell ML Nicholson 2000 Molecular changes in extracellular matrix turnover after renal ischemia-reperfusion injury Br J Surg 87 1188 1192 1:STN:280:DC%2BD3M%2Fjs1Oktw%3D%3D 10.1046/j.1365-2168.2000.01499.x 10971426
26. KB Jin HJ Choi HT Kim, et al. 2008 Cytokine array after cyclosporine treatment in rats Transplant Proc 40 2682 2684 1:CAS:528:DC%2BD1cXht1eitrjI 10.1016/j.transproceed.2008.08.008 18929835
27. EA Jones DA Shoskes 2000 The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair J Urol 163 999 1004 1:CAS:528:DC%2BD3cXhsVSju74%3D 10.1016/S0022-5347(05)67871-8 10688038
28. E Kovesdi A Tamas D Reglodi, et al. 2008 Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats Neurotox Res 13 71 78 1:CAS:528:DC%2BD1cXosFGhu70%3D 10.1007/BF03033558 18515209
29. OR Kunduzova G Escourrou F De la Farge, et al. 2004 Involvement of peripheral benzodiazepine receptor in the oxidative stress, death-signaling pathways, and renal injury induced by ischemia-reperfusion J Am Soc Nephrol 15 2152 2160 1:CAS:528:DC%2BD2cXlvVKmu7g%3D 10.1097/01.ASN.0000133563.41148.74 15284300
30. M Li JL Maderdrut JJ Lertora A Arimura V Batuman 2008 Renoprotection by pituitary adenylate cyclase activating polypeptide in multiple myeloma and other kidney diseases Regul Pept 145 24 32 1:CAS:528:DC%2BD2sXhsVOltrvE 10.1016/j.regpep.2007.09.012 17935800
31. J Melendez-Zajgla L Del Pozo G Ceballos V Maldonado 2008 Tissue inhibitor of metalloproteinases-4. The road less traveled Mol Cancer 7 85 10.1186/1476-4598-7-85 19025595
32. SF Nilsson 1994 PACAP-27 and PACAP-38: vascular effects in the eye and some other tissues in the rabbit Eur J Pharmacol 253 17 25 1:CAS:528: DyaK2cXhvVentr8%3D 10.1016/0014-2999(94)90752-8 7912197
33. DJ Oh B Dursun Z He, et al. 2008 Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice Am J Renal Physiol 294 F264 F271 1:CAS:528:DC%2BD1cXhtVKnu7c%3D 10.1152/ajprenal.00204.2007
34. H Ohtaki T Nakamachi K Dohi S Shioda 2008 Role of PACAP in ischemic neural death J Mol Neurosci 36 16 25 1:CAS:528:DC%2BD1cXhsVagtLvJ 10.1007/s12031-008-9077-3 18483879
35. B Racz B Gasz B Borsiczky, et al. 2007 Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis Gen Comp Endocrinol 153 115 123 1:CAS:528: DC%2BD2sXotlSit7g%3D 10.1016/j.ygcen.2006.12.006 17270184
36. B Racz B Gasz F Gallyas Jr, et al. 2008 PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis Regul Pept 145 105 115 1:CAS:528:DC%2BD2sXhsVOltrrJ 10.1016/j.regpep.2007.09.015 17981349
37. M Riera J Torras JM Cruzado, et al. 2001 The enhancement of endogenous cAMP with pituitary adenylate cyclase activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response Transplantation 72 1217 1223 1:CAS:528:DC%2BD3MXosV2qsrw%3D 10.1097/00007890- 200110150-00006 11602845
38. P Saikumar MA Venkatachalam 2003 Role of apoptosis in hypoxic/ischemic damage in the kidney Semin Nephrol 23 511 521 1:CAS:528:DC%2BD2cXisVWn 10.1053/S0270-9295(03)00130-X 14631559
39. E Scharf V May KM Brras KC Shutz Y Mao-Draayer 2008 Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) regulate murine neurak progenitor cell survival, proliferation and differentiation J Mol Neurosci 36 79 88 1:CAS:528:DC%2BD1cXhsVagtLnM 10.1007/s12031-008-9097-z 18629655
40. S Shioda H Ohtaki T Nakamachi, et al. 2006 Pleiotropic functions of PACAP in the CNS. Neuroprotection and neurodevelopment Ann N Y Acad Sci 1070 550 560 1:CAS:528:DC%2BD28XpvVegsrs%3D 10.1196/annals.1317.080 16888224
41. A Somogyvari-Vigh D Reglodi 2004 Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide-review Curr Pharm Des 10 2861 2889 1:CAS:528:DC%2BD2cXmslKkuro%3D 10.2174/1381612043383548 15379674
42. P Szakaly P Kiss A Lubics, et al. 2008 Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia/reperfusion J Mol Neurosci 36 89 96 1:CAS:528:DC%2BD1cXhsVagtLvP 10.1007/s12031-008-9064-8 18478450
43. A Tamas D Reglodi Z Szanto, et al. 2002 Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats Neuroendocrinol Lett 23 249 254 1:CAS:528:DC%2BD38XlvVKntrg%3D 12080287
44. A Tominaga H Sugawara K Inoue A Miyata 2008 Implication of pituitary adenylate cyclase activating polypeptide (PACAP) for neuroprotection of nicotinic acetylcholine receptor signaling in PC12 cells J Mol Neurosci 36 73 78 1:CAS:528:DC%2BD1cXhsVagtL3F 10.1007/s12031-008-9127-x 18626793
45. AJ Turunen JA Fernandez L Lindgrem, et al. 2005 Activated protein C reduces graft neutrophil activation in clinical renal transplantation Am J Transplant 5 2204 2212 1:CAS:528:DC%2BD2MXhtVeku7%2FP 10.1111/j.1600-6143.2005. 00994.x 16095499
46. A Vannay A Fekete R Langer, et al. 2009 Dehydroepoandrosterone pretreatment alters the ischaemia/reperfusion-induced VEGF, IL-1, and IL-6 gene expression in acute renal failure Kidney Blood Press Res 32 175 184 1:CAS:528:DC%2BD1MXhtFalurfJ 10.1159/000224629 19521107
47. G Varbiro B Veres F Gallyas Jr, et al. 2001 Direct effect of Taxol on free radical formation and mitochondrial permeability transition Free Radic Biol Med 31 548 558 1:CAS:528:DC%2BD3MXlslGnuro%3D 10.1016/S0891-5849(01)00616-5 11498288
48. D Vaudry C Rousselle M Basille, et al. 2002 Pituitary adenylate cyclase activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death Proc Natl Acad Sci USA 99 6398 6403 1:CAS:528:DC%2BD38XjslWnt7s%3D 10.1073/pnas.082112699 11972030
49. D Vaudry A Falluel-Morel A Bourgault, et al. 2009 Pituitary adenylate cyclase activating polypeptide and its receptors: 20 years after the discovery Pharmacol Rev 61 283 357 10.1124/pr.109.001370 19805477
50. J Wang Q Wei CY Wang, et al. 2004 Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria J Biol Chem 279 19948 19954 1:CAS:528:DC%2BD2cXjs1Whsr8%3D 10.1074/jbc.M313629200 15004018
51. CW Yang SW Lim KW Han, et al. 2001 Upregulation of ciliary neurotrophic factor (CNTF) and CNTF receptor alpha in rat kidney with ischemia-reperfusion injury J Am Soc Nephrol 12 749 757 1:CAS:528:DC%2BD3MXjtVWgtrk%3D 11274236
52. T Yin G Sandhu CD Wolfgand, et al. 1997 Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney J Biol Chem 272 19943 19950 1:CAS:528:DyaK2sXltlGktrs%3D 10.1074/jbc.272.32.19943 9242662
53. M Yoshiyama WC de Groat 2008 The role of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide in the neural pathways controlling the lower urinary tract J Mol Neurosci 36 227 240 1:CAS:528:DC%2BD1cXhsVagtLjK 10.1007/s12031-008-9090-6 18677446